Vifor Pharma AG

Vifor Pharma AG

Vifor Pharma AG

Overview
Date Founded

1927

Headquarters

Rechenstrasse 37,St. Gallen, Sankt Gallen (St Gall) 9014

Type of Company

Public

Employees (Worldwide)

2,600

Industries

Pharmaceuticals
Wholesale: Consumer Non-Durables/Sundries
Retail: Drug Stores

Company Description

Vifor Pharma AG is a pharmaceutical company, which engages in the research, development, production, and marketing of therapeutic products. It operates through the following geographical segments: Switzerland, Europe, USA, Rest of World, and Group. The firm offers products for iron deficiency, nephrology, and cardio-renal therapies. The company was founded in 1927 and is headquartered in St. Gallen, Switzerland.

Contact Data
Trying to get in touch with decision makers at Vifor Pharma AG? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer

Chief Financial Officer

Chief Business Officer

Chief Medical Officer

Chief Strategy Officer

Chief Executive Officer, Galenica Santé

Head of Legal

Director

Director

Board of Directors

Partner at Sofinnova Partners SAS

Former General Counsel & Member of the Executive Board at Credit Suisse Group AG

Former President & Chief Executive Officer at Straumann Holding AG

Former President at Eli Lilly & Company

President at Swiss Society of Nephrology

Head of International Commercial at Shire Plc

Chairman & President at Neue Zürcher Zeitung AG

Partner at EQT Partners AB

Former Executive Vice President-Research & Development & Chief Scientific Officer at Ipsen SA

Paths to Vifor Pharma AG
Potential Connections via
Relationship Science
You
Vifor Pharma AG
Owners & Shareholders
Details Hidden

Mirabeaud Suisse is an active, convictions-based, benchmark-aware manager which helps portfolio managers to make informed decisions and generate performance while protecting investors on the downside. They are an asset allocation and multi-asset portfolio management specialist which bases their investment process on qualitative, quantitative and technical inputs with different risk-return profiles and levels of reactivity in order to match investor needs.For equities, the firm selects stocks based on conviction, flexibility and integrated risk management. They focus on specific segments of the fixed-income universe, offering investors innovative investment solutions using credit, duration and convexity as sources of performance. They are geared towards asymmetry and offset their equity upside participation with a bond floor for downside protection.Mirabaud Suisse combines investment grade, high yield and government bonds in dynamic ways to generate positive total returns, including during interest normalization phases. Their dynamic approach for multi asset portfolios allows them to capture smaller trends and deliver performance while protecting the downside.

Details Hidden

VV is an active, value-oriented investor and manages funds against the SPI Small & Mid Caps index with a medium to long-term outlook. The firm's portfolios are primarily invested in small- and mid-caps from Switzerland or Lichtenstein with a sector focus on industrials.VV utilizes fundamental bottom-up research in order to identify well-managed, undervalued companies with a healthy balance sheet, a proven management team, a strong market position or market leadership and significant unexploited market opportunity. The firm primarily relies on external fundamental research, and uses quantitative tools in their risk and exposure control process.

Details Hidden

BlackRock AM Schweiz is an active, risk-aware manager which offers clients a range of investment solutions across asset classes and regions, including equity, fixed-income, multi-asset, money market, index, absolute return, natural resources and equity income. The firm seeks to combine the global investment expertise of BlackRock for investors in Switzerland.

Recent Transactions
Details Hidden

Vifor Pharma AG purchases Inositec AG

Details Hidden

Vifor Pharma AG purchases Sanifit Therapeutics SA

Details Hidden

Vifor Pharma AG, Vifor (International) AG purchase ChemoCentryx, Inc. from GlaxoSmithKline Plc

Transaction Advisors
Legal Advisor

Advised onVifor Pharma AG purchases Relypsa, Inc.

Accountant

Advised onVifor Pharma AG purchases Pharma-Singer AG

Legal Advisor

Advised onVifor Pharma AG purchases Aspreva Pharmaceuticals Corp.

Legal Advisor

Advised onVifor Pharma AG purchases Relypsa, Inc.

Legal Advisor

Advised onVifor Pharma AG purchases Relypsa, Inc.

Advisors & Consultants
Advisor

Chairman & President at Neue Zürcher Zeitung AG

Clients

Fresenius Medical Care AG & Co. KGaA engages in the provision of products and services for patients with chronic kidney failure. It also develop and manufacture a variety of health care products, which includes dialysis and non-dialysis products. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.

Zeria Pharmaceutical Co., Ltd. engages in the manufacture, sale, import and export of pharmaceutical products. It operates through the following segments: Ethical Pharmaceuticals, Consumer Healthcare, and Others. The Ethical Pharmaceuticals segment deals with the research, development, and distribution of medical drugs. The Consumer Healthcare segment manufactures, supplies, and markets self-medication over-the-counter (OTC) drugs, health foods, quasi drugs, and cosmetics. The Others segment includes insurance and real estate businesses. It also develops and distributes agricultural and industrial chemicals, and reagents. The company was founded in December 22, 1955 and is headquartered in Tokyo, Japan.

Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.

Key Stats and Financials As of 2020
Market Capitalization
$7.42B
Total Enterprise Value
$9.67B
Earnings Per Share
$2.69
Revenue
$1.76B
Three Year Compounded Annual Growth Rate Of Revenue
8.32%
Debt TEV
0.07x
TEVNet Income
55.42x
Enterprise Value EBITDAOperating
19.54x
Enterprise Value / Sales
5.49x
EBITDAMargin
28.1%
Total Equity
$4.15B
Total Debt
$638M
EBITDA
$495M
Net Profit
$175M
Investments
Details Hidden

Genedata AG transforms data into intelligence with a portfolio of advanced software solutions. Its products include biologics, screener, expressionist, profiler, analyst, phylosospher, selector, imagence and bioprocess. The firm offers data analysis, information technology, training, software, development and hosting services to pharmaceutical, agrochemical, Industrial biotechnology companies and non-profit research organizations. The company was founded by Othmar Pfannes in 1997 and is headquartered in Basel, Switzerland.

Suppliers
Roche Holding AG Hospitals & Patient Services | Basel, Switzerland

Roche Holding ag Roche Personalised Healthcare – our mission The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines. These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’. At Roche, ‘Personalised Healthcare’ is at the core of our business strategy

Relypsa, Inc. Pharmaceuticals | Redwood City, CA

Relypsa, Inc. operates as a bio-pharmaceutical company, which engages in the development and commercialization of late-stage medicines in the iron deficiency, nephrology, and cardio-renal therapeutic areas. It offers Veltassa, a potassium binder approved for the treatment of hyperkalemia. The company was founded by Jerry M. Buysse, Gerrit Klaerner, Michael Burdick, Jay P. Shepard, Detlef F. Albrecht, George Tyson, Sandra I. Coufal and Vic Ciaravino on October 29, 2007 and is headquartered in Redwood City, CA.

Pfizer, Inc. Medical Support Services | New York, NY

Pfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Vifor Pharma AG. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Vifor Pharma AG's profile does not indicate a business or promotional relationship of any kind between RelSci and Vifor Pharma AG.